综述
ENGLISH ABSTRACT
莫西沙星前房注射预防白内障术后细菌性眼内炎的研究进展
严唯佳
周海燕 [综述]
严宏 [综述]
作者及单位信息
·
DOI: 10.3760/cma.j.cn115989-20210304-00146
Research progress of intracameral moxifloxacin in the prevention of bacterial endophthalmitis after cataract surgery
Yan Weijia
Zhou Haiyan
Yan Hong
Authors Info & Affiliations
Yan Weijia
Yan Weijia is now a doctoral student of Department of Ophthalmology, Heidelberg University Hospital, Heidelberg 69120, Germany
Xi'an People's Hospital (Xi'an Fourth Hospital), Shaanxi Eye Hospital, Affiliated Guangren Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710004, China
Zhou Haiyan
Department of Ophthalmology, Shaanxi Provincial People's Hospital, Xi'an 710068, China
Yan Hong
Xi'an People's Hospital (Xi'an Fourth Hospital), Shaanxi Eye Hospital, Affiliated Guangren Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710004, China
·
DOI: 10.3760/cma.j.cn115989-20210304-00146
741
120
0
0
9
0
PDF下载
APP内阅读
摘要

白内障术后眼内炎(POE)是一种罕见的威胁视力的并发症,在我国的发病率为0.033%~0.11%。近几年有大量的病例对照研究和回顾性系列病例分析研究指出,白内障术毕前房注射抗生素可有效降低细菌性眼内炎的发生率,其中常用的药物包括头孢呋辛、万古霉素和莫西沙星。由于全球各地POE致病菌种类、抗生素的可获得性、成本效益等因素存在差异,药物的选择也存在很大差异。前房内注射抗生素引起的不良事件屡见发生,包括过量注射头孢呋辛导致的黄斑水肿、视网膜血管渗漏和葡萄膜炎,万古霉素引起出血性闭塞性视网膜血管炎等并发症。莫西沙星作为第4代氟喹诺酮类药物对细菌性眼内炎有明显的预防作用。本文着重归纳了近5年前房注射抗生素预防POE研究结果,就莫西沙星在细菌性眼内炎预防、药物安全性、前房药物持续时间以及成本效益方面进行综述。

前房注射;细菌性眼内炎;白内障术后;莫西沙星;头孢呋辛;万古霉素
ABSTRACT

Postoperative endophthalmitis (POE) is a serious vision-threatening complication of cataract surgery, with an incidence rate of 0.033%-0.11% in China.In recent years, numerous retrospective studies and data analyses have reported that intracameral injection of antibiotics can effectively reduce the incidence of bacterial endophthalmitis, which commonly include cefuroxime, vancomycin and moxifloxacin.Globally, due to factors such as the availability, cost-effectiveness, and types of pathogens of POE, the drug choice varies to a large extent.Adverse events caused by antibiotics in the intracameral injection often occur, including macular edema, retinal vascular leakage, and uveitis caused by overdose of cefuroxime, and complications such as hemorrhagic retinal vasculitis obliterans due to vancomycin.Moxifloxacin, as a fourth-generation fluoroquinolone, has a significant effect on the prevention of bacterial endophthalmitis.Studies in the past five years related to moxifloxacin, and the significant advantages of moxifloxacin in the prevention of bacterial endophthalmitis, drug safety, duration of intracameral drug, and cost-effectiveness were summarized in this article.

Injections, anterior chamber;Endophthalmitis, bacterial;Cataract, postoperative;Moxifloxacin;Cefuroxime;Vancomycin
Yan Hong, Email: mocdef.labiamtohst8212nay
引用本文

严唯佳,周海燕,严宏. 莫西沙星前房注射预防白内障术后细菌性眼内炎的研究进展[J]. 中华实验眼科杂志,2022,40(05):461-465.

DOI:10.3760/cma.j.cn115989-20210304-00146

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
白内障术后眼内炎(postoperative endophthalmitis,POE)是严重威胁视力的并发症,通常由毒力较强的细菌感染导致 [ 1 ]。据统计,我国大型眼科机构POE的发病率为0.033% [ 2 ],中小型眼科机构的发病率高达0.11%,发达国家POE的发病率为0.012%~0.053% [ 3 ]。国内外相关研究指出,术前眼睑和结膜囊聚维酮碘消毒、术毕前房内注射抗生素以及术后局部应用抗生素滴眼液这3种措施对预防POE明确有效 [ 4 , 5 ]。其中,前房注射抗生素可以直接、快速地使眼内抗生素达到峰值,抑制术中操作带入的细菌。该方法安全、经济,同时提高了药物的利用率 [ 6 ]。欧洲白内障和屈光外科医师协会于2007年发表的前瞻性随机试验研究结果表明,前房注射抗生素(头孢呋辛1 mg/0.1 ml)可以使POE的发生率降低83% [ 7 ]。在美国白内障和屈光手术协会(ASCRS)调查中,眼科医生在白内障术毕常规前房内注射抗生素的比率从2007年的30%和2014年的50%增加到2021年的66% [ 8 ]。目前,世界范围内常规白内障术毕前房注射抗生素预防术后细菌性眼内炎的比率持续增加,但临床医生对前房注射抗生素预防POE尚未达成共识。因此,亟需更加有说服力的临床病例、前瞻性试验数据等为前房注射抗生素提供更好的指导。有关前房注射头孢呋辛和万古霉素的临床研究较多,近年对前房注射莫西沙星有新的研究成果,本文重点就前房注射抗生素类型、前房注射莫西沙星预防POE的研究进行综述,以期为POE临床治疗方案的选择提供参考。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Wang XL , Huang XY , Wang Z et al. The anterior chamber injection of moxifloxacin injection to prevent endophthalmitis after cataract surgery:a meta-analysis[J/OL]J Ophthalmol 20202020:7242969[2021-07-22]http://www.ncbi.nlm.nih.gov/pubmed/32908685. DOI: 10.1155/2020/7242969 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Yao K , Zhu Y , Zhu Z et al. The incidence of postoperative endophthalmitis after cataract surgery in China:a multicenter investigation of 2006-2011[J]Br J Ophthalmol 201397(10):1312-1317. DOI: 10.1136/bjophthalmol-2013-303282 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Miller JJ , Scott IU , Flynn HW Jret al. Acute-onset endophthalmitis after cataract surgery (2000-2004):incidence,clinical settings,and visual acuity outcomes after treatment[J]Am J Ophthalmol 2005139(6):983-987. DOI: 10.1016/j.ajo.2005.01.025 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Olson RJ , Braga-Mele R , Chen SH et al. Cataract in the adult eye preferred practice pattern ® [J]Ophthalmology 2017124(2):P1-P119. DOI: 10.1016/j.ophtha.2016.09.027 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
郭小红周鹏卢奕白内障术毕应用聚维酮碘对术后眼内炎预防效果的研究[J]中华实验眼科杂志 201432(9):854-855. DOI: 10.3760/cma.j.issn.2095-0160.2014.09.019 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Kishore K , Brown JA , Satar JM et al. Acute-onset postoperative endophthalmitis after cataract surgery and transzonular intravitreal triamcinolone-moxifloxacin[J]J Cataract Refract Surg 201844(12):1436-1440. DOI: 10.1016/j.jcrs.2018.07.055 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Endophthalmitis Study Group,European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery:results of the ESCRS multicenter study and identification of risk factors[J]J Cataract Refract Surg 200733(6):978-988. DOI: 10.1016/j.jcrs.2007.02.032 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Chang DF , Rhee DJ . Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery:results of the 2021 ASCRS member survey[J]J Cataract Refract Surg 202248(1):3-7. DOI: 10.1097/j.jcrs.0000000000000757 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Williamson K Intraocular antibiotics as endophthalmitis prophylaxis in routine cataract surgery[J]Adv Ophthalmol Optom 20183(1):407-421. DOI: 10.1016/j.yaoo.2018.05.005 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Rathi VM , Sharma S , Das T et al. Endophthalmitis prophylaxis study.Report 1:intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India[J]Indian J Ophthalmol 202068(5):819-824. DOI: 10.4103/ijo.IJO_1400_19 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Ma X , Xie L , Huang Y Intraoperative cefuroxime irrigation prophylaxis for acute-onset endophthalmitis after phacoemulsification surgery[J]Infect Drug Resist 202013:1455-1463. DOI: 10.2147/IDR.S252674 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
卢奕郑天玉前房内注射抗生素预防白内障摘除手术后眼内炎的意义[J]中华眼科杂志 201854(5):339-342. DOI: 10.3760/cma.j.issn.0412-4081.2018.05.006 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Melega MV , Alves M , Cavalcanti Lira RP et al. Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis:randomized controlled clinical trial[J]J Cataract Refract Surg 201945(3):343-350. DOI: 10.1016/j.jcrs.2018.10.044 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Yannuzzi NA , Si N , Relhan N et al. Endophthalmitis after clear corneal cataract surgery:outcomes over two decades[J]Am J Ophthalmol 2017174:155-159. DOI: 10.1016/j.ajo.2016.11.006 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Friling E , Montan P Bacteriology and cefuroxime resistance in endophthalmitis following cataract surgery before and after the introduction of prophylactic intracameral cefuroxime:a retrospective single-centre study[J]J Hosp Infect 2019101(1):88-92. DOI: 10.1016/j.jhin.2018.02.005 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Haripriya A , Chang DF , Ravindran RD . Endophthalmitis reduction with intracameral moxifloxacin prophylaxis:analysis of 600 000 surgeries[J]Ophthalmology 2017124(6):768-775. DOI: 10.1016/j.ophtha.2017.01.026 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Au CP , White AJ , Healey PR . Efficacy and cost-effectiveness of intracameral vancomycin in reducing postoperative endophthalmitis incidence in Australia[J]Clin Exp Ophthalmol 201644(9):803-811. DOI: 10.1111/ceo.12789 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Schelonka LP , SaBell MA . Postcataract endophthalmitis prophylaxis using irrigation,incision hydration,and eye pressurization with vancomycin[J]Clin Ophthalmol 20159:1337-1345. DOI: 10.2147/OPTH.S79119 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Moser CL , Lecumberri Lopez M , Garat M et al. Prophylactic intracameral cefazolin and postoperative topical moxifloxacin after cataract surgery:endophthalmitis risk reduction and safety results in a 16-year study[J]Graefe's Arch Clin Exp Ophthalmol 2019257(10):2185-2191. DOI: 10.1007/s00417-019-04417-9 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Nicholson LB , Kim BT , Jardón J et al. Severe bilateral ischemic retinal vasculitis following cataract surgery[J]Ophthalmic Surg Lasers Imaging Retina 201445(4):338-342. DOI: 10.3928/23258160-20140605-01 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Todorich B , Faia LJ , Thanos A et al. Vancomycin-associated hemorrhagic occlusive retinal vasculitis:a clinical-pathophysiological analysis[J]Am J Ophthalmol 2018188:131-140. DOI: 10.1016/j.ajo.2018.01.030 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
U.S.Food & Drug Administration. A case of hemorrhagic occlusive retinal vasculitis (HORV) following intraocular injections of a compounded triamcinolone,moxifloxacin,and vancomycin formulation[EB/OL].(2017-10-03)[2021-08-28]https://www.fda.gov/drugs/human-drug-compounding/case-hemorrhagic-occlusive-retinal-vasculitis-horv-following-intraocular-injections-compounded.
返回引文位置Google Scholar
百度学术
万方数据
[23]
Cavalcanti Lira RP , Lucena NP , Ferreira KS et al. Long-term safety of intracameral moxifloxacin after cataract surgery[J]J Cataract Refract Surg 201743(1):139-140. DOI: 10.1016/j.jcrs.2016.11.040 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Lucena NP , Pereira I , Gaete M et al. Intracameral moxifloxacin after cataract surgery:a prospective study[J]Arq Bras Oftalmol 201881(2):92-94. DOI: 10.5935/0004-2749.20180022 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
Bowen RC , Zhou AX , Bondalapati S et al. Comparative analysis of the safety and efficacy of intracameral cefuroxime,moxifloxacin and vancomycin at the end of cataract surgery:a meta-analysis[J]Br J Ophthalmol 2018102(9):1268-1276. DOI: 10.1136/bjophthalmol-2017-311051 .
返回引文位置Google Scholar
百度学术
万方数据
[26]
Haripriya A , Chang DF , Ravindran RD . Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications:results from 2 million consecutive cataract surgeries[J]J Cataract Refract Surg 201945(9):1226-1233. DOI: 10.1016/j.jcrs.2019.04.018 .
返回引文位置Google Scholar
百度学术
万方数据
[27]
Arshinoff SA , Felfeli T , Modabber M Aqueous level abatement profiles of intracameral antibiotics:a comparative mathematical model of moxifloxacin,cefuroxime,and vancomycin with determination of relative efficacies[J]J Cataract Refract Surg 201945(11):1568-1574. DOI: 10.1016/j.jcrs.2019.06.009 .
返回引文位置Google Scholar
百度学术
万方数据
[28]
Shenoy P , Goh E , Kashikar R et al. Impact of prophylactic intracameral moxifloxacin on post-cataract surgery endophthalmitis:data from a tertiary eye care facility in rural India[J]Int Ophthalmol 202141(8):2729-2736. DOI: 10.1007/s10792-021-01830-0 .
返回引文位置Google Scholar
百度学术
万方数据
[29]
Bhatta S , Pant N , Poudel M Postoperative endophthalmitis with and without intracameral moxifloxacin prophylaxis in a high volume surgery setting[J/OL]BMJ Open Ophthalmol 20216(1):e000609[2021-08-30]http://www.ncbi.nlm.nih.gov/pubmed/34179508. DOI: 10.1136/bmjophth-2020-000609 .
返回引文位置Google Scholar
百度学术
万方数据
[30]
Shorstein NH , Liu L , Carolan JA et al. Endophthalmitis prophylaxis failures in patients injected with intracameral antibiotic during cataract surgery[J]Am J Ophthalmol 2021227:166-172. DOI: 10.1016/j.ajo.2021.02.007 .
返回引文位置Google Scholar
百度学术
万方数据
[31]
Dave VP , Singh VM , Reddy JC et al. Clinical features and microbiology of post-cataract surgery endophthalmitis with and without intracameral moxifloxacin prophylaxis:endophthalmitis prophylaxis study report 3[J]Indian J Ophthalmol 202270(1):158-163. DOI: 10.4103/ijo.IJO_1405_21 .
返回引文位置Google Scholar
百度学术
万方数据
[32]
Lipsky L , Barrett G Intracameral antibiotics for prophylaxis of postoperative endophthalmitis in Australia:a review[J]Clin Exp Ophthalmol 201947(4):537-541. DOI: 10.1111/ceo.13419 .
返回引文位置Google Scholar
百度学术
万方数据
[33]
管怀进重视白内障超声乳化手术对眼内组织的影响[J]中华实验眼科杂志 202139(4):273-279. DOI: 10.3760/cma.j.cn115989-20200424-00283 .
返回引文位置Google Scholar
百度学术
万方数据
Guan HJ . Paying close attention to the impact of cataract phacoemulsification surgery on ocular tissue[J]Chin J Exp Ophthalmol 202139(4):273-279. DOI: 10.3760/cma.j.cn115989-20200424-00283 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[34]
Ferreira BG , Cardoso da Silva I , Mélega MV et al. Macular and choroidal thickness after intracameral moxifloxacin for prevention of postcataract endophthalmitis[J]J Cataract Refract Surg 202147(1):40-45. DOI: 10.1097/j.jcrs.0000000000000365 .
返回引文位置Google Scholar
百度学术
万方数据
[35]
Leung EH , Gibbons A , Stout JT et al. Intracameral moxifloxacin for endophthalmitis prophylaxis after cataract surgery:cost-effectiveness analysis[J]J Cataract Refract Surg 201844(8):971-978. DOI: 10.1016/j.jcrs.2018.05.022 .
返回引文位置Google Scholar
百度学术
万方数据
[36]
汤欣周臻肖博前房内注射抗生素在预防白内障摘除手术后眼内炎中的合理应用[J]中华眼科杂志 201854(5):334-338. DOI: 10.3760/cma.j.issn.0412-4081.2018.05.004 .
返回引文位置Google Scholar
百度学术
万方数据
[37]
Stringham JD , Relhan N , Miller D et al. Trends in fluoroquinolone nonsusceptibility among coagulase-negative staphylococcus isolates causing endophthalmitis,1995-2016 [J]JAMA Ophthalmol 2017135(7):814-815. DOI: 10.1001/jamaophthalmol.2017.1826 .
返回引文位置Google Scholar
百度学术
万方数据
[38]
Grzybowski A , Brona P , Zeman L et al. Commonly used intracameral antibiotics for endophthalmitis prophylaxis:a literature review[J]Surv Ophthalmol 202166(1):98-108. DOI: 10.1016/j.survophthal.2020.04.006 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
严宏,Email: mocdef.labiamtohst8212nay
B
所有作者均声明不存在利益冲突
C
国家自然科学基金面上项目 (82070947)
陕西省重点研发计划项目 (2021ZDLSF-08)
西安英才计划项目 (XAYC200021)
国家建设高水平大学公派研究生项目 (202108080147)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号